27.08.2018 13:00:22
|
DGAP-News: On growth path with top-class medicine: M1 Kliniken AG increases sales by +30% in the first half of 2018
DGAP-News: M1 Kliniken AG / Key word(s): Half Year Results On growth path with top-class medicine: M1 Kliniken AG increases sales by +30% in the first half of 2018 - Sales EUR 28.9 million (H1/17: EUR 22.3 million) "The utilisation of our 20 ambulatory specialist centres for beauty treatments and the Schlossklinik in Berlin has developed satisfactorily. After opening five specialist centers in the second half of 2017, we were able to put two more centers into operation in the first half of this year," says Dr. Walter von Horstig, member of the Management Board of M1 Kliniken AG. "In addition to operational growth, we have also invested in the future. Among other things, we opened the first center for aesthetic dental treatment in our clinic in Berlin. In recent months we have been able to establish medical and business processes in order to quickly expand throughout Germany with the new "M1 Dental" brand." Despite the up-front costs of the large number of new locations and investments in new treatment areas, the M1 Group continues to grow profitably: earnings before tax (EBT) in the first half of 2018 were at EUR 4.3 million (H1 2017: EUR 4.2 million). The EBT margin is thus in the targeted corridor. Positive outlook: New specialist centres, entry into aesthetic dentistry and international expansion "The market for plastic and aesthetic treatments continues to offer significant growth potential to the M1 Group. This applies to our existing treatments and, of course, to new markets. With our strategy - top-class medicine at a fair price - we will continue to promote innovations and actively develop markets in the future," says Patrick Brenske, member of the Management Board of M1 Kliniken AG. "We will also roll out our business model internationally and make M1 the leading beauty brand in Europe." The Half-Year Report 2018 of M1 Kliniken AG is available for download at www.m1-kliniken.de Details of the M1 Kliniken AG share Contact
27.08.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | M1 Kliniken AG |
Grünauer Straße 5 | |
12557 Berlin | |
Germany | |
Phone: | +49 (0)30 347 47 44 14 |
Fax: | +49 (0)30 347 47 44 17 |
E-mail: | ir@m1-kliniken.de |
Internet: | https://www.m1-kliniken.de |
ISIN: | DE000A0STSQ8 |
WKN: | A0STSQ |
Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart, Tradegate Exchange |
End of News | DGAP News Service |
|
708755 27.08.2018
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu M1 Kliniken AGmehr Nachrichten
19.11.24 |
EQS-News: M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets (EQS Group) | |
19.11.24 |
EQS-News: M1 Kliniken AG steigert operativen Gewinn (EBIT) um 71 % in den ersten neun Monaten 2024 und bestätigt Mittelfristziele (EQS Group) | |
03.09.24 |
EQS-News: Operativer Gewinn (EBIT) fast verdoppelt: M1 Kliniken AG wächst auch in H1 2024 deutlich (EQS Group) | |
03.09.24 |
EQS-News: Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024 (EQS Group) | |
21.06.24 |
EQS-News: M1 Kliniken AG: Management Board confirms growth targets (EQS Group) | |
21.06.24 |
EQS-News: M1 Kliniken AG: Vorstand bestätigt Wachstumsziele (EQS Group) | |
20.06.24 |
EQS-DD: M1 Kliniken AG: Attila Strauss, Verkauf (EQS Group) | |
20.06.24 |
EQS-DD: M1 Kliniken AG: Attila Strauss, sell (EQS Group) |